Kisspeptin, the product of the KISS1 gene, plays an essential role in the regulation of spermatogenesis acting primarily at the hypothalamic level of the gonadotropic axis.
Introduction
Mammalian sperm acquire the ability to fertilize an egg during their transit through the female reproductive tract (Chang, 1951 , Suarez & Pacey, 2006 Visconti, 2009) . During this time, sperm cells undergo a series of morphological and functional modifications leading to activation of sperm motility, development of hyperactivated motility, binding to oocyte zona pellucida and the acrosome reaction (AR) (Roldan et al., 1994; Flesch & Gadella, 2000; Visconti et al., 2002; Grasa et al., 2006; Bedu-Addo et al., 2008) . For this capacitation to take place, sperm must send and receive specific signals from the environment, which must be properly decoded under a precise spatio-temporal regulation.
This complex process involves activation of multiple signal transduction mechanisms which lead to increases in sperm [Ca 2+ ] i , cAMP, pH i , and phosphorylation of some proteins at serine/threonine and tyrosine residues (Rossato et al., 2001; Visconti et al., 1999 Visconti et al., , 2002 Darszon et al., 2006; Lamirande & O'Flaherty, 2008; Publicover et al., 2008) . However, the precise nature of sequentially activated receptors and channels in the sperm plasma membrane remains incompletely understood.
During the past years, kisspeptins have emerged as essential regulators of reproductive function (de Roux et al., 2003; Seminara et al., 2003) . Kisppeptins are primarily synthesized in discrete neuronal populations within the hypothalamus where they modulate GnRH secretion and, thereby, gonadotropin release (Navarro et al., 2004; Colledge, 2008; TenaSempere, 2010) . These peptides are encoded by the KISS1 gene which produces a Cterminal amidated peptide of 54 amino-acids named kisspeptin-54 (formerly, also known as metastin). Kisspeptin-54 is further processed to generate C-terminal peptides of 14 4 (kisspeptin-14), 13 (kisspeptin-13) or 10 amino-acids (kisspeptin-10), all of them showing similar biological activities (Colledge, 2008; Tena-Sempere, 2010) .
Kisspeptin effects are mediated by activation of the KISS1 receptor (KISS1R), also known as GPR54, which is encoded by the KISS1R gene (Ohtaki et al., 2001 , Colledge, 2008 .
Mutations of KISS1R are associated with hypogonadotrophic hypogonadism in humans (Seminara et al., 2003; de Roux et al., 2003) , a phenotype which is also observed in mice carrying inactivating mutations of Kiss1 or Kiss1r genes (Tena-Sempere, 2010) .
In addition to their prominent expression at hypothalamic levels, fragmentary evidences suggest that KISS1 and/or KISS1R mRNAs or proteins are also present in several peripheral reproductive tissues including the ovary (Castellano et al., 2006; Gaytan et al., 2009) , the oviduct (Gaytán et al., 2007) and the testes (Ohtaki et al., 2001) . On the latter, however, the potential effects of kisspeptin on the male gonads and, particularly, its possible role in the regulation of ejaculated sperm function have not been studied to date.
The aim of this work was to examine the presence of the kisspeptin system in human spermatozoa and its potential involvement in the regulation of human sperm function. supplemented with 10 mM HEPES and 0.5% bovine serum albumin (BSA) and processed as described previously (Ravina et al., 2007; Pinto et al. 2009) . Briefly, sperm suspensions were centrifuged through a discontinuous density gradient (Spermgrad-125, Vitrolife, Kungsbacka, Sweden), allowed to swim-up for 1 hour at 37ºC and the supernatant carefully aspirated. Sperm motility and concentration were re-examined and the concentration adjusted to 50 x 10 6 cells/ml for subsequent experiments.
Materials and methods

Semen samples and sperm preparation
Indirect immunofluorescence
Immunolocalization of kisspeptin and its receptor was assessed by fluorescence microscopy.
Sperm cells were washed, resuspended in phosphate-buffered saline (PBS) and smeared onto poly-L-lysine-coated slides. Spermatozoa were then fixed by incubation in cold methanol (-20ºC) for 20 min. Slides were washed thoroughly with PBS and incubated for 120 min with 2% casein in PBS to block non-specific binding sites. Test slides were incubated overnight at 4ºC with a primary polyclonal antibody designed to recognize human kisspeptin (either sc-15400, from Santa Cruz Biotechnology, Santa Cruz, CA, dilution 1:400, or T-4771, from Bachem, Bubendorf, CH, dilution 1:200), or KISS1R (sc-48220, Santa Cruz, dilution 1:600). The specificity of antibodies was previously established by one of us (Gaytán et al., 2007) or assessed by using sections of human ovary and oviduct as positive controls (Gaytán et al., 2007 (Gaytán et al., , 2009 
Western Blot experiments
Western blotting was used to analyze the presence of KISS1R in spermatozoa and to assess the specificity of the KISS1R antibody. This procedure was performed as described previously, with slight modifications (Ravina et al., 2007; Pinto et al., 2009) . We also studied the presence of KISS1R in human placenta, used as a positive control (Ohtaki et al., 2001 ). For extraction of total proteins, the sperm cells were subjected to sonication in urea extraction buffer (1% w/v SDS, 9 M Urea, 1 mM EDTA, 0. were incubated in mHTF with the acetoxymethyl ester form of Fura-2 (Fura-2/AM, 10 μM, Invitrogen) for 60 min at room temperature. After loading, the cells were washed and resuspended in mHTF or in a solution of the following composition (mM): NaCl 140; KCl 4.7; CaCl 2 2.0; MgCl 2 0.3; glucose 10 and HEPES 10 (pH 7.4). Sperm aliquots (1 ml, 10 x 10 6 cells/ml) were placed in the cuvette of a spectrofluorometer (SLM Aminco-Bowman, Series 2, Microbeam, Barcelona, Spain) and continuously stirred at 37ºC. The sperm suspension was alternatively illuminated with two excitations wavelengths (340 nm and 380 nm) and the emitted fluorescence was measured at 510 nm. Changes in [Ca 2+ ] i were monitored using the Fura-2 (F340/F380) fluorescence ratio as previously described (Pinto et al., 2009) .
Sperm Motility Studies
Motility kinematics parameters were evaluated by computer analysis with Sperm Class Analyzer (SCA, Microptic, Barcelona, Spain) following WHO recommendations (1999).
Aliquots of semen samples (5 μL) were placed into a Makler counting chamber (Sefi We also analysed the effects of kisspeptin or solvent on hyperactivation in sperm capacitated in vitro by incubation for 6 h in a humidified incubator at 37ºC in 5% CO 2 . The following kinematics parameters were measured: hyperactive motility; curvilinear velocity (VCL , μm/s); straight-line velocity (VSL, μm/s), average-path velocity (VAP , μm/s); 9 amplitude of lateral head displacement (ALH, μm); beat-cross frequency (BCF, Hz); linearity (LIN=VSL/VCL x 100) and straightness (STR=VSL/VAP x 100). These values were then expressed as percentage changes induced by kisspeptin using the formula:
kisspeptin treated-solvent-treated/solvent-treated x 100.
Acrosome reaction assays
Acrosomal status was assessed with fluorescein isothyocianate-conjugated lectin from
Pisum sativum (FITC-PSA) following previously described procedures (Mendoza et al., 1992; Bedu-Addo et al., 2005) . Following swim-up, sperm cells were adjusted to a concentration of 10 x 10 6 cells/ml and capacitated (6 h at 37ºC in 5% CO 2 ). Sperm aliquots were then untreated (time-matched paired controls) or treated for different times with kisspeptin (10 μM), the ionophore A23187 (10 μM) or the corresponding solvent at 37ºC, 5% CO 2 . At the end of each incubation period, cells were centrifuged, the supernatant removed and spermatozoa resuspended in hypo-osmotic swelling (HOS) medium (0.74% sodium citrate and 1.35% fructose in ultra-pure H 2 O) as described by Bedu-Addo et al. 
Statistical analysis
Results shown represent means ± SEM and n indicates number of experiments in sperm amples from n different donors. Kisspeptin responses were observed in 65-70% of sperm preparations assayed and only these samples were considered for mean calculation.
Statistical analyses were made using Mann-Whitney's U test (for comparison of mean ranks between two groups) or Kruskal-Wallis test (to compare more than two groups) nonparametric tests. These procedures were undertaken using GRAPHPAD PRISM (version 5.0). P<0.05 values were considered significant.
Results
Immunodetection of kisspeptin and its receptor in human sperm
Immunocytochemistry studies showed the presence of kisspeptin and KISS1R immunoreactivity (IR) in human spermatozoa (Figs. 1, 2, 3 ). For kisspeptin, positive immunolabeling was found in 100% of cells in all samples assayed (n= 6). Kisspeptin IR was localized in the post-acrosomal region of the sperm head and, in most cells, it was particularly intense in the equatorial segment (Figs. 1, 3) . In many spermatozoa, an additional positive labeling was observed around the neck (Figs. 1, 3) . In some sperm preparations (n=2), kisspeptin IR was restricted to the equatorial segment and the neck while in other preparations (n=4) kisspeptin-positive labeling was also observed in the 11 flagellum midpiece (Figs. 1, 3) . We used two different kisspeptin antibodies and found comparable results with both of them. Fig. 1 The kisspeptin receptor showed a distribution similar to that of kisspeptin; KISS1R IR was mainly found in the equatorial segment of the sperm head and around the neck (Figs. 2, 3 ).
Strong immunostaining for KISS1R in these two regions was found in approximately 95%
of cells (n=6, Fig. 2 ). In addition, approximately a 30-40 % of spermatozoa showed positive immunolabeling in the flagellum midpiece and this was observed in all preparations assayed (n=6, Figs. 2, 3 ). Control assays incubated only with secondary antibodies showed no signal.
Western blot analysis of sperm homogenates confirmed the presence of KISS1R in spermatozoa. The KISS1R antibody recognized a band with the expected molecular weight of approximately 43 kDa (Fig. 2) and also labeled other bands of similar size, which may be the result of post-translational modifications (Fig. 2) . The immunoreactive bands for KISS1R were also observed in the human placenta, used as positive control (Fig. 2) . No band was observed in control assays, where primary antibodies were omitted (not shown).
Fig. 2
Co-localization of kisspeptin and neurokinin B in human sperm
In a previous study we showed the presence of positive immunoreactivity for NKB in human spermatozoa (Pinto et al., 2010) . In this study, we performed double immunolabeling experiments with anti-kisspeptin and anti-NKB antibodies to analyze the localization of NKB and kisspeptin in the same sperm cells. We found, in agreement with our previous results (Pinto et al., 2010) , that NKB immunofluorescence was localized in the 12 sperm head and was particularly intense in the equatorial region (Fig. 1) . Double immunofluorescence analysis confirmed the co-localization of both peptides in sperm cells, where kisspeptin and NKB appeared to uniformly merge, particularly over the equatorial segment (yellow signal, Fig. 1 ).
Co-localization of kisspeptin and its receptor in human sperm
Double immunolabeling experiments showed co-expression of kisspeptin and KISS1R in human sperm cells (Fig. 3) . Fluorescence images show that co-localization of both proteins was mostly confined to the equatorial segment (Fig. 3) . (Fig. 5A) . At a higher concentration (10 μM), kisspeptin caused a rapid stimulation of sperm progressive motility and increased both a grade and b grade spermatozoa (Fig. 5B) , which result in a net increase in sperm progressive motility (Fig. 5C ). This lasted for approximately 15 min, and was followed by a decrease in the percentage of a+b grade sperm cells (Fig. 5C) . A new phase of stimulation of progressive motility was observed at more prolonged times of incubation (60-120 min, Figs. 5B and 5C). The effects of kisspeptin on sperm motility were inhibited in the presence of the KISS1R antagonist, p234 (Fig. 5C ). With regard to sperm kinematics parameters, kisspeptin increased ALH and BCF causing a parallel decrease in straightness and linearity (P<0.05 vs. solvent-treated aliquots, Fig. 6 ).
This led to a motility pattern characteristic of hyperactivated sperm which was transiently maintained (Fig 6) . The effects of kisspeptin on hyperactive motility were reduced in the presence of the antagonist p234 (Fig. 6 ).
There were considerable variations between samples with respect to i) their ability to respond to kisspeptin and ii) the time needed to reach maximal responses. Hence, the effects of kisspeptin 1 μM on sperm motility were observed in 4 of 5 experiments. The effects of 10 μM kisspeptin were observed in 5 of 7 sperm samples in experiments performed in the absence of the antagonist, and in 8 of 14 experiments in the presence of p234 or its solvent.
Sperm hyperactivation was observed in 9 of 14 experiments. Within these 9 responsive samples, 5 showed hyperactivation at 2 min, all were hyperactivated at 15 min, 7 remained hyperactive at 30 min and 4 displayed hyperactive motility at 60 min.
Fig. 6
Effect of kisspeptin on the acrosome reaction
We then analyzed whether kisspeptin was able to induce the AR in human sperm capacitated for 6 h and then exposed to kisspeptin (10 μM) for different times. As shown in Fig. 7 , kisspeptin did not induce the AR at any of the times assayed (2-120 min, Fig. 7 ).
Conversely, A23187 (10 μM) induced the AR in time-matched paired sperm aliquots ( Fig.   7 ) while its solvent had no effect. 
DISCUSSION
To date, the effects of kisspeptin on reproduction have been mainly studied at the hypothalamic-pituitary levels (Colledge, 2008 , Tena-Sempere, 2010 . In this sense, it remains undisputed that kisspeptin act through its receptor, KISS1R, in hypothalamic neurons and play an essential role in the regulation of sexual maturation, gametogenesis and fertility (de Roux et al., 2003; Seminara et al., 2003; Navarro et al., 2004 , Colledge, 2008 , Tena-Sempere, 2010 . Evidence for the expression of KISS1 and KISS1R genes in the human testis had been presented preliminarily (Ohtaki et al., 2001) , suggesting that kisspeptin could exert direct actions in the male gonads. Our present data are fully compatible with this possibility as we show, for the first time, that kisspeptin and its receptor are present in mature human spermatozoa, with specific patterns of cellular distribution. The strongest immunolabeling for both kisspeptin and KISS1R was found in the equatorial segment, a region with an important role in oocyte-sperm fusion (Bedford et al., 1979; Flesch & Gadella, 2000) . In most cells, kisspeptin and its receptor were also localized around the neck, a region that participates in the regulation of flagellar activity Bedu-Addo et al., 2008) . In a smaller population of spermatozoa, kisspeptin and KISS1R were also found in the midpiece, a region involved in the control of energetic requirements, Ca 2+ -buffering and motion (Suarez et al., 2007; Publicover et al., 2008) .
Kisspeptin is expressed in discrete populations of neurons within the hypothalamus, including the arcuate nucleus, where it is co-expressed with two other bioactive peptides, the tachykinin NKB and the opioid dynorphin A (Rance, 2009; Lehman et al., 2010; TenaSempere, 2010) . These are named KNDy neurons, and play a crucial role in the pathway 16 through which the brain regulates reproduction (Topaloglu et al., 2009; Lehman et al., 2010) . The present data show that NKB co-localizes with kisspeptin also in human spermatozoa, particularly in the equatorial region. Dynorphin is also present in human sperm and is mainly localized in the equatorial segment (N. Subiran, personal communication). Thus, spermatozoa represent the first known type of non-neuronal KNDy cell. In hypothalamic neurons, kisspeptin, NKB and dynorphin appear to act in a coordinated manner to modulate pulsatile GnRH secretion and hence gonadotropin release (Lehman et al., 2010) . It may thus be tempting to propose that some of the effects of kisspeptin in sperm, modulated by the concerted actions of NKB and dynorphin, may stem from its ability to locally modulate GnRH secretion. Previous studies have demonstrated the presence of GnRH and the GnRH receptor in many extrahypothalamic tissues including the human oviduct, ovarian granulosa cells and spermatozoa (Izumi et al., 1985; Morales, 1998; Lee et al., 2000) . Experimental data have shown that GnRH increases the ability of sperm to bind to the zona pellucida, whereas it is unable to induce the AR or to modify the motility pattern in human sperm (Morales, 1998) . In any event, our current data suggest that kisspeptin, alone or in concert with NKB (and dynorphin) is capable to modulate important sperm functions. The physiological relevance of such a local role of kisspeptin, as well as NKB and dynorphin, in human sperm awaits further investigation.
The presence of kisspeptin and its receptor in spermatozoa strongly suggest a regulatory role of the kisspeptin system. Because [Ca 2+ ] i signaling plays a central role in the control of many different sperm functions (Rossato et al., 2001; Darszon et al., 2006; Publicover et al., 2008) , we analyzed the ability of kisspeptin to induce changes in sperm response induced by kisspeptin was very different in time-course and kinetics to that induced by progesterone. Moreover, both kisspeptin and progesterone were able to induce a full response in sperm preparations previously exposed to the other compound (see Fig. 4 (Mortimer, 1997; Turner, 2006; Subiran et al., 2008) . When sperm cells arrive to the oviduct, they develop a hyperactivated motility characterized by the appearance of asymmetric trajectories, which is necessary for sperm to leave their reservoirs in the oviductal isthmus, in order to find and fuse with the oocyte (Mortimer, 1997; Suarez & Pacey, 2006; Chang & Suarez, 2010) . Previous studies have
shown that kisspeptin is present in the oviduct, it being particularly abundant in the luminal surface of the isthmus segment (Gaytan et al., 2007) . Kisspeptin could thus participate in some of the important processes that occur in the oviduct, such as sperm hyperactivation, the acrosome reaction and/or oocyte fertilization (Roldan et al., 1994; Visconti,. 2009; 18 Chang & Suarez, 2010) . The present data show that the effects of kisspeptin on motility were characterized by an increase in flagellar beating and in ALH with a concomitant decrease in straightness and linearity, leading to motility trajectories that are characteristics of hyperactivated spermatozoa. The transient nature of kisspeptin-induced hyperactivation is consistent with the hypothesis that sperm flagellar beat pattern must turn intermittently between asymmetrical and symmetrical swimming patterns in order to reach the oocyte (Chang & Suarez, 2010) . On the contrary, kisspeptin was unable to induce the AR, which is consistent with the very different [Ca 2+ ] i response elicited by kisspeptin in comparison with that of progesterone, a well-known AR inducer (Roldan et al., 1994; Bedu-Addo et al., 2005) . Further studies will help to clarify the role of kisspeptin and KISS1R in oocyte fertilization.
In this study, kisspeptin immunoreactivity was found in 100% of sperm cells and KISS1R immunoreactivity was found in approximately 95% of cells, indicating a wide distribution of both kisspeptin and its receptor in sperm cells. In addition, there were differences in subcellular immunolocalization between sperm cells, which is an usual fact when working with spermatozoa (see Agirregoitia et al., 2006; Subiran et al., 2008; Colas et al., 2009) . At the moment, the most accepted explanation is that these differences may reflect changes in the capacitation stage of the sperm cell (Colas et al., 2009) . KISS1R, the protein that would mediate functional responses to kisspeptin, was found in both the equatorial segment and around the neck in more than 95% of cells and was additionally found in the flagellum midpiece in about 30-40% of cells, and this occur in all preparations assayed. With respect to functional experiments, we found that approximately a 30% of sperm preparations did no 19 respond to kisspeptin. These data do not permit actually to establish a correlation between changes in immunolocalization and the functional responses to kisspeptin.
In conclusion, this study shows for the first time that kisspeptin and its receptor are present in human spermatozoa. Moreover, we document that kisspeptin, acting through KISS1R, is able to modulate some human sperm functions. The physiological significance of this novel facet of kisspeptin action upon the male reproductive axis warrants further investigation. 
